MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.exphem.2025.104859

Медицинская библиотека · Experimental hematology · 2025

Impaired CMV-specific CD4+ T-cell reconstitution is associated with CMV infection after letermovir cessation.

Wang Luxiang, Li Su, Huang Jiayu, Zhang Zilu, Pan Zengkai, Jiang Chuanhe, Lu Haiyang, Zhang Sujiang, Cao Yang, Cai Xiaohong, Cai Gang, Hu Xiaoxia

СтатьяПеревод в очереди

Аннотация

Cytomegalovirus (CMV) is a prevalent virus that causes substantial morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo-HSCT). Although letermovir (LTV) prophylaxis has revolutionized CMV management, clinically significant CMV infection (cs-CMVi) after letermovir cessation presents a new challenge. Effective CMV control is heavily dependent on the reconstitution of CMV-specific cell-mediated immunity (CMI); however, there is a lack of reliable immunologic biomarkers for identifying cs-CMVi after LTV withdrawal. The aim of the present study was to determine how different CMV preventive regimens and cs-CMVi impacted CMV-CMI reconstitution and the risk factors for late-onset cs-CMVi after LTV cessation. The patients were divided into the preemptive therapy (PET, n = 55) and LTV (n = 23) groups. LTV was significantly more effective at decreasing the cumulative incidence of cs-CMVi than PET (4.3% vs. 65.4%, p < 0.01) within 100 days post-allo-HSCT. Meanwhile, after day 100, the cumulative incidence of late-onset cs-CMVi was higher in the LTV than in the PET group (26.1% vs. 7.3%, p = 0.02). We found that LTV delayed the reconstitution of CMV-specific CD8+ T cells. Patients who experienced cs-CMVi had lower CMV-specific interferon (IFN)-γ+CD4+ T-cell counts than those who did not develop cs-CMVi. Patients with CMV disease had the lowest numbers of CMV-specific polyfunctional CD4+ T cells. Polyfunctional CMV-specific CD4+ T-cell count < 2.01 cells/µL might predict late-onset cs-CMVi after LTV cessation (50.0% vs. 7.69%, p = 0.04). Our findings establish an association between CMV prophylaxis, cs-CMVi, and CMV-specific T-cell response reconstitution post-allo-HSCT.

Для цитирования: Wang Luxiang, Li Su, Huang Jiayu, Zhang Zilu, Pan Zengkai, Jiang Chuanhe, Lu Haiyang, Zhang Sujiang, Cao Yang, Cai Xiaohong, Cai Gang, Hu Xiaoxia. Impaired CMV-specific CD4+ T-cell reconstitution is associated with CMV infection after letermovir cessation.. Experimental hematology. 2025. DOI: 10.1016/j.exphem.2025.104859.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.